Orchard Therapeutics Announces That OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agency
London, UK, August 22, 2017 / B3C newswire / -- Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company developing transformative gene therapies for patients with severe inherited orphan diseases, today announces that the UK …